Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 51 for:    tazarotene

A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® (Tazarotene) Cream, 0.1% in the Topical Treatment of Acne Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03341910
Recruitment Status : Completed
First Posted : November 14, 2017
Last Update Posted : October 8, 2019
Sponsor:
Information provided by (Responsible Party):
Dr. Reddy's Laboratories Limited

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 18, 2018
Actual Study Completion Date : May 18, 2018
Certification/Extension First Submitted : September 24, 2019